Home
|
Services
|
Expertise
|
Fees
|
Resources
|
FAQ
|
Community Services
|
Useful Links
Trademark
Patent
Design
Copyright
Enforcement
IP Investigation
Border Control
GI
Procedure
Filing Requirement
FAQ
Publication
Prosecution
Opposition
India
Pakistan
Bangladesh
Registering Brands
Trademark Opposition
Benefits for both parties
Use of mark in Indian market necessary to establish prior rights India
India announces accession to Madrid protocol
Prosecution Strategies
Global Brands in India
Procedure
Filing Requirement
FAQ
Publication
Prosecution
Pre-grant Opposition
Post-grant Opposition
Patent Filing India
Requirement for PCT Filing
Merck refused interim injunction for the infringement of its patent on Anti Diabetic drug
India – more good news for the generics industry as Supreme Court rejects Novartis appeal
Ericsson Vs Micromax: Indian Courts suggest License on ‘Frand’ Terms
India – boost to generics industry - IPAB approves compulsory licence under Bayer’s ‘Nexavar’ patent
Compulsory Licence - Sharing the medicine
Procedure
Filing Requirement
FAQ
Prosecution
Cancellation
FAQ
Publication
Protection of publicity and image rights
Copyright - The sound of copyright
Civil
Criminal
Publication
FAQ
Fighting the crime of the 21st century
Customs circular - parallel imports are legitimate India
WTMLR–India enforcement May 2011
Exhaustion in India – When is it a national issue?
IP in India – Keep your wits about you
Procedure
Filing Requirement
FAQ
Publication
Customs circular - parallel imports are legitimate India
High Court issues - clarity on parallel imports
Conflicting views on parallel imports lead to confusion for brand owners and importers
Exhaustion in India - When is it a national issue?
Filing Requirement
Article
Overview
Basmati, Pashminas and The Law
A guide to protecting geographical indications in India
The quality and depth of Ranjan Narula Associates IP resources
gives it, and its clients, an edge in the marketplace
Home
>>
Resources
Alerts
Our Publications
Our Brochure
>>
Alerts
Merck refused interim injunction for the infringement of its patent on Anti Diabetic drug
India – more good news for the generics industry as Supreme Court rejects Novartis appeal
Ericsson Vs Micromax: Indian Courts suggest License on ‘Frand’ Terms
Basmati, Pashminas and The Law
A guide to protecting geographical indications in India
Trade Marks Office Initiates Special Project to Clear Backlog
Roche 'Pegasys' Patent Revoked by Appeal Board
Gujarat High Court clarifies extent of use necessary to maintain registration
Controller prohibits amendments to trade mark Statements of User
PCT national phase filing procedure simplified
1
2
3
Copyright © 2012 Ranjan Narula Associates
Terms of Use
l
Feedback
l
Disclaimer
l
Sign in